Zymergen (Zymergen) Days Payable : 90.24 (As of Jun. 2022)

View and export this data going back to 2021. Start your Free Trial

What is Zymergen Days Payable?

Zymergen's average Accounts Payable for the three months ended in Jun. 2022 was $9.62 Mil. Zymergen's Cost of Goods Sold for the three months ended in Jun. 2022 was $9.73 Mil. Hence, Zymergen's Days Payable for the three months ended in Jun. 2022 was 90.24.

The historical rank and industry rank for Zymergen's Days Payable or its related term are showing as below:

ZY' s Days Payable Range Over the Past 10 Years
Min: 45.85 Med: 50.65 Max: 73.64
Current: 73.64

During the past 3 years, Zymergen's highest Days Payable was 73.64. The lowest was 45.85. And the median was 50.65.

ZY's Days Payable is not ranked
in the Chemicals industry.
Industry Median: 61 vs ZY: 73.64

Zymergen's Days Payable increased from Jun. 2021 (64.41) to Jun. 2022 (90.24). It may suggest that Zymergen delayed paying its suppliers.

Zymergen Days Payable Historical Data

The historical data trend for Zymergen's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zymergen Days Payable Chart

Zymergen Annual Data

Trend

Dec19

Dec20

Dec21

Days Payable

50.65

56.67

45.85

Zymergen Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22
Days Payable	Get a 7-Day Free Trial						64.41	65.63	75.65	43.19	90.24

Competitive Comparison of Zymergen's Days Payable

For the Specialty Chemicals subindustry, Zymergen's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zymergen's Days Payable Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Zymergen's Days Payable distribution charts can be found below:

* The bar in red indicates where Zymergen's Days Payable falls into.

Zymergen Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Zymergen's Days Payable for the fiscal year that ended in Dec. 2021 is calculated as

	Days Payable (A: Dec. 2021 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2020 )	+	Accounts Payable (A: Dec. 2021 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2021 )	*	Days in Period
=	( (12.097	+	5.418)	/	2 )	/	69.721	*	365
=	8.7575					/	69.721	*	365
=	45.85

Zymergen's Days Payable for the quarter that ended in Jun. 2022 is calculated as:

	Days Payable (Q: Jun. 2022 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Mar. 2022 )	+	Accounts Payable (Q: Jun. 2022 ))	/	count )	/	Cost of Goods Sold (Q: Jun. 2022 )	*	Days in Period
=	( (6.371	+	12.877)	/	2 )	/	9.732	*	365 / 4
=	9.624					/	9.732	*	365 / 4
=	90.24

Zymergen Days Payable Related Terms

Thank you for viewing the detailed overview of Zymergen's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Zymergen (Zymergen) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Zymergen Inc (NAS:ZY) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

5980 Horton Street, Suite 105, Emeryville, CA, USA, 94608

Website

https://www.zymergen.com

Zymergen Inc is a biofacturing company. Zymergen partners with nature to design, develop and manufacture bio-based breakthrough products that deliver value to customers in a broad range of industries. A unique combination of biology, chemistry, software and automation enables the company to design and create new materials.

Executives

Enakshi Singh	officer: Chief Financial Officer	5980 HORTON ST., STE 105 EMERYVILLE CA 94608
Mina Kim	officer: Chief Legal Officer	C/O ACELYRIN, INC., 4149 LIBERTY CANYON RD., AGOURA HILLS CA 91301
Zachariah Serber	director, officer: Chief Science Officer	5980 HORTON ST., STE 105 EMERYVILLE CA 94608
Aaron Kimball	officer: Chief Technology Officer	5980 HORTON ST., STE 105 EMERYVILLE CA 94025
Jay T Flatley	director	9885 TOWNE CENTRE DR, SAN DIEGO CA 92121
Svf Excaliber (cayman) Ltd	10 percent owner	27 HOSPITAL ROAD, WALKERS CORPORATE LTD., CAYMAN CORPORATE CENTRE, GEORGE TOWN, GRAND CAYMAN E9 KY-9008
Josh Hoffman	director, officer: Chief Executive Officer	5980 HORTON ST., STE 105 EMERYVILLE CA 94608
Erik Jedidiah Dean	officer: VP Operations and Engineering	5980 HORTON ST., STE 105 EMERYVILLE CA 94608
Rohit Sharma	director	575 HIGH STREET PALO ALTO CA 94301
Travis Murdoch	director	1 CIRCLE STAR WAY SAN CARLOS CA 94070
Matthew Ocko	director	270 UNIVERSITY AVENUE, PALO ALTO CA 94301
Svf Endurance (cayman) Ltd	10 percent owner	C/O WALKERS CORPORATE LIMITED, 27 HOSPITAL ROAD, GEORGE TOWN E9 KY1-9008
Softbank Vision Fund (aiv M1) L.p.	10 percent owner	251 LITTLE FALLS DRIVE, WILMINGTON DE 19808
Sb Investment Advisers (uk) Ltd	10 percent owner	69 GROSVENOR STREET, LONDON X0 W1K 3JP
Christine Marie Gorjanc	director	4500 GREAT AMERICA PARKWAY, SANTA CLARA CA 95054